Nexgel, Inc. NXGL
Institutional shares held
659,184
0
calls
0
puts
Total value of holdings
$1.56M
$0
calls
$0
puts
Market Cap
$13.2M
5,572,230
Shares Out.
Institutional ownership
11.83%
# of Institutions
18
We take great care to ensure that the data presented and summarized in this overview for NEXGEL, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NXGL
View all-
Evernest Financial Advisors, LLC Carmel, IN225KShares$530,2110.26% of portfolio
-
Morgan Stanley New York, NY87.8KShares$207,2170.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.6KShares$192,6490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$156,8140.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50.1KShares$118,2400.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38.5KShares$90,7630.03% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$84,2870.01% of portfolio
-
Ifp Advisors, Inc22KShares$51,9200.0% of portfolio
-
Flaharty Asset Management, LLC19KShares$44,8400.01% of portfolio
-
State Street Corp Boston, MA17.3KShares$40,7310.0% of portfolio
Latest Institutional Activity in NXGL
Top Purchases
Top Sells
About NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Insider Transactions at NXGL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.27%
|
$6,000
$2.57 P/Share
|
|
Jun 11
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.55%
|
$4,000
$2.39 P/Share
|
|
Jun 09
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.55%
|
$4,000
$2.33 P/Share
|
|
Jun 05
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$2,000
$2.32 P/Share
|
|
Jun 04
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$2,000
$2.29 P/Share
|
|
May 30
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$2,000
$2.22 P/Share
|
|
May 16
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$2,000
$2.58 P/Share
|
|
May 12
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.22%
|
$6,000
$2.69 P/Share
|
|
Apr 10
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.17%
|
$6,000
$2.61 P/Share
|
|
Apr 01
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.07%
|
$12,000
$3.01 P/Share
|
|
Mar 10
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.13%
|
$6,000
$2.87 P/Share
|
|
Mar 03
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.06%
|
$12,000
$3.16 P/Share
|
|
Feb 12
2025
|
Scott Robert Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.74%
|
-
|
|
Feb 12
2025
|
Steven Mark Glassman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.57%
|
-
|
|
Feb 10
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.12%
|
$9,000
$3.27 P/Share
|
|
Feb 03
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.05%
|
$12,000
$3.64 P/Share
|
|
Jan 07
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.08%
|
$9,000
$3.37 P/Share
|
|
Jan 02
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.04%
|
$12,000
$3.96 P/Share
|
|
Jan 02
2025
|
Adam R. Levy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,116
+6.33%
|
-
|
|
Dec 20
2024
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.03%
|
$12,000
$4.64 P/Share
|
Last 12 Months Summary
Buy / Acquisition
120K
Shares
From
9
Insiders
| Open market or private purchase | 89.3K shares |
|---|---|
| Grant, award, or other acquisition | 31.1K shares |
Sell / Disposition
49K
Shares
From
3
Insiders
| Open market or private sale | 45K shares |
|---|---|
| Bona fide gift | 4K shares |